IPO Preview: Cathay Industrial Biotech
By IPOdesktop: Based in Shanghai, China, Cathay Industrial Biotech [proposed symbol (CBIO)] scheduled a $90 million IPO with a market capitalization of $611 million at the price range mid-point of $13 for Thursday, August 11, 2011. The full IPO calendar for the week of August 8 includes 12 scheduled IPOs trying to raise almost $2 billion. OBSERVATIONS -- "China’s Stocks Decline to 6-Week Low on Manufacturing Slowdown, Inflation." (Bloomberg link). CONCLUSION -- CBIO is losing money and has big expansion plans. However, in this uncertain market it may be best not to chase after Chinese IPOs.
CBIO Valuation Metrics
BUSINESS -- Each ADS represents three ordinary shares, par value US$0.001 per share. CBIO is a leading global industrial biotechnology company as measured by production capacity in key biochemical products and a pioneer in the commercialization of bioprocess technologies. CBIO products address the specialty chemicals and biofuels markets. CBIO applies proprietary technologies toComplete Story »